Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Allergology International : Official Journal of the Japanese Society of Allergology|April 25, 2020
Cough persistence in adults with chronic cough: A 4-year retrospective cohort studySung-Yoon Kang, Woo-Jung Song, Ha-Kyeong Won, et al.
The Lancet. Respiratory Medicine|September 20, 2017
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trialSurinder S Birring, Marlies S Wijsenbeek, Sanjay Agrawal, et al.
The European Respiratory Journal|April 27, 2019
The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled studyAlyn H Morice, Michael M Kitt, Anthony P Ford, et al.
Allergy, Asthma & Immunology Research|September 16, 2020
Impact of Chronic Cough on Health-Related Quality of Life in the Korean Adult General Population: The Korean National Health and Nutrition Examination Survey 2010-2016Ha Kyeong Won, Ji Hyang Lee, Jin An, et al.
Therapeutic Advances in Respiratory Disease|July 30, 2025
Azithromycin and oesophageal motility in chronic respiratory disease: a feasibility studyDominic L Sykes, Kayleigh Brindle, Rohan Menon, et al.
Lung|November 17, 2019
Characterisation of a New Human Alveolar Macrophage-Like Cell Line (Daisy)Laura R Sadofsky, Yvette A Hayman, Jesse Vance, et al.
Cough (London, England)|October 8, 2010
Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on coughAlex Molassiotis, Jaclyn A Smith, Mike I Bennett, et al.
ERJ Open Research|December 2, 2020
Azithromycin for sarcoidosis cough: an open-label exploratory clinical trialSimon D Fraser, Susannah Thackray-Nocera, Marica Shepherd, et al.
Cells|June 13, 2014
Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing CellsLaura R Sadofsky, Koti T Sreekrishna, Yakang Lin, et al.
Lung|April 7, 2021
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist GefapixantAlyn H Morice, Surinder S Birring, Jaclyn A Smith, et al.
Pageof 16